Copyright 2009 Medical News Today Latest Immune System / Vaccines News From Medical News Today. http://www.medicalnewstoday.com/sections/immune_system/ admin@medicalnewstoday.com (MNT Admin) editors@medicalnewstoday.com (MNT Editors) en-us Sun, 08 Nov 2009 04:00:00 PST http://www.medicalnewstoday.com/articles/170251.php http://www.medicalnewstoday.com/articles/170251.php A new national poll from Harvard School of Public Health (HSPH) researchers found that a majority of adults who tried to get the H1N1 vaccine for themselves or their children have been unable to do so. The poll, which examines the American public's response to the H1N1 vaccine shortage, is the fifth in a series of surveys of public views concerning the H1N1 flu outbreak undertaken by the Harvard Opinion Research Program at HSPH. The polling was done October 30 to November 1, 2009. Swine Flu Sun, 08 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/170224.php http://www.medicalnewstoday.com/articles/170224.php The distribution of swine flu vaccines to big name companies in New York has caused an uproar as people complain that children and health care workers should receive top priority. The Swine Flu Sun, 08 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/170230.php http://www.medicalnewstoday.com/articles/170230.php The H1N1 (swine flu) virus is now the dominant flu strain worldwide, the WHO reported Thursday, with the virus accounting for up to 70 percent of the flu viruses sampled in some countries, the Associated Press reports. Swine Flu Sat, 07 Nov 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/170190.php http://www.medicalnewstoday.com/articles/170190.php CEL-SCI Corporation (NYSE Amex: CVM), a developer of vaccines and therapeutics for the prevention and treatment of infectious diseases and a late-stage oncology company, announced today that an Institutional Review Board of The Johns Hopkins University School of Medicine (Johns Hopkins) has given clearance for the Company's first clinical study to proceed. As a result, Johns Hopkins will host the study, which will be led by Principal Investigator Jonathan M. Swine Flu Sat, 07 Nov 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/170202.php http://www.medicalnewstoday.com/articles/170202.php Novartis announced that it received approval from the German regulatory authorities for its adjuvanted cell culture-based Influenza A(H1N1) 2009 monovalent vaccine, Celtura®. Novartis continues to pursue registration in other major countries, including Japan and Switzerland. Swine Flu Sat, 07 Nov 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/170118.php http://www.medicalnewstoday.com/articles/170118.php When it comes to plants' innate immunity, like many of the dances of life, it takes two to tango. A receptor molecule in the plant pairs up with a specific molecule on the invading bacteria and, presto, the immune system swings into action to defend against the invasion of the disease-causing microbe. Infectious Diseases / Bacteria / Viruses Sat, 07 Nov 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/170127.php http://www.medicalnewstoday.com/articles/170127.php The Journal of Infectious Diseases has released a special edition, Global Rotavirus Surveillance: Preparing for the Introduction of Rotavirus Vaccines. This special edition provides a significant contribution to the understanding of rotavirus disease burden and the impact of rotavirus vaccines, which have the potential to save an estimated 228,000 lives annually. Infectious Diseases / Bacteria / Viruses Fri, 06 Nov 2009 17:00:00 PST http://www.medicalnewstoday.com/articles/170148.php http://www.medicalnewstoday.com/articles/170148.php A new study provides evidence that ImmunoLin®, an all natural and GRAS approved source of immunoglobulin, will provide immediate benefit to the function of the immune system and the gut. Immunoglobulins, or antibodies, are specialized proteins found in blood that the immune system naturally produces for immunity. Immune System / Vaccines Fri, 06 Nov 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/170062.php http://www.medicalnewstoday.com/articles/170062.php An experimental vaccine to treat precancerous vulvar growths eliminated the growths in nine of 20 women participating in a small trial, according to a study published in the New England Journal of Medicine, Reuters reports. Women's Health / Gynecology Fri, 06 Nov 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/170129.php http://www.medicalnewstoday.com/articles/170129.php A key player in a cascade that likely begins with stress and leads to high blood pressure and kidney damage has been identified by researchers who say the finding may lead to better ways to control both. Medical College of Georgia researchers have found endothelin, a powerful blood vessel constrictor and inflammatory peptide, increases the number of T cells in the kidneys, which helps recruit other immune cells, causing inflammation and destruction. Hypertension Fri, 06 Nov 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/170143.php http://www.medicalnewstoday.com/articles/170143.php Researchers at Yale University have developed synthetic molecules capable of enhancing the body's immune response to HIV and HIV-infected cells, as well as to prostate cancer cells. Their findings, published online in the Journal of the American Chemical Society, could lead to novel therapeutic approaches for these diseases. HIV / AIDS Fri, 06 Nov 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/170153.php http://www.medicalnewstoday.com/articles/170153.php In diseases such as multiple sclerosis, cells of the immune system infiltrate the brain tissue, where they cause immense damage. For many years, it was an enigma as to how these cells can escape from the bloodstream. This is no trivial feat, given that specialized blood vessels act as a barrier between the nervous system and the bloodstream. Until now, tissue sections provided the sole evidence that the immune cells really do manage to reach the nerve cells. Multiple Sclerosis Fri, 06 Nov 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/170092.php http://www.medicalnewstoday.com/articles/170092.php U.S. health officials briefing Congress on Wednesday would not outline a timeline for when enough H1N1 (swine flu) vaccines would be available to reach all high-risk populations in the country, the Washington Post reports. Swine Flu Fri, 06 Nov 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/170093.php http://www.medicalnewstoday.com/articles/170093.php The Wall Street Journal examines "big pharma's growing interest in a corner of healthcare - emerging-market inoculations," in light of a recent move by Novartis to purchase an 85 percent stake in the Chinese vaccine maker Zhejiang Tianyuan Bio-Pharmaceutical Co. Pharma Industry / Biotech Industry Fri, 06 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/170053.php http://www.medicalnewstoday.com/articles/170053.php A powerful new biosensor developed by European researchers will help identify cells in the immune system that actively suppress tumour growth, then put them to use. Enlisting the patient's own immune system would be like sending reinforcements for resistance fighters. Cancer / Oncology Fri, 06 Nov 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/170023.php http://www.medicalnewstoday.com/articles/170023.php Raynaud's is a common condition, especially in teenagers, affecting approximately 10 million people in the UK. It can vary from being mild to very severe but in many cases is no more than a nuisance in cold weather. However, for the 1 in 10,000 who develop Raynaud's after the age of 30, it could be the first sign of a serious underlying condition called scleroderma. Immune System / Vaccines Fri, 06 Nov 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/169997.php http://www.medicalnewstoday.com/articles/169997.php The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded approximately $208 million to two programs that support research to better understand the human immune response to emerging and re-emerging infectious diseases, including those that may be introduced into a community through acts of bioterrorism. Immune System / Vaccines Fri, 06 Nov 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/170001.php http://www.medicalnewstoday.com/articles/170001.php Patients experiencing septic shock who receive inappropriate therapy may have a fivefold reduction in survival, shows a new study. Researchers from the University of Manitoba, Winnipeg, MB, Canada, retrospectively reviewed the cases of 5,715 patients with septic shock to determine the appropriateness of initial antimicrobial therapy, clinical infection site, and relevant pathogens. Immune System / Vaccines Thu, 05 Nov 2009 21:00:00 PST http://www.medicalnewstoday.com/articles/170000.php http://www.medicalnewstoday.com/articles/170000.php Antigenics, Inc. (NASDAQ: AGEN) today indicated that GlaxoSmithKline's (GSK) Phase III malaria vaccine clinical trial, containing Antigenics' QS-21 Stimulon® adjuvant, has enrolled more than 5,000 children to date and is expected to involve up to 16,000 children. The pivotal efficacy study of RTS,S, the world's most clinically advanced malaria vaccine, is ongoing in seven African countries. Tropical Diseases Thu, 05 Nov 2009 04:00:00 PST http://www.medicalnewstoday.com/articles/169925.php http://www.medicalnewstoday.com/articles/169925.php The International Examines Contributing Factors To Uneven Distribution Of Childhood Vaccines As a follow-up to the release of the State of the World's Vaccines and Immunization by the WHO, UNICEF and World Bank last month, Immune System / Vaccines Thu, 05 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/169920.php http://www.medicalnewstoday.com/articles/169920.php Subsidized artemisinin-based combination therapies (ACTs) under the Affordable Medicines Facility - malaria (AMFm) program will be available in select countries "in two week's time," Tropical Diseases Thu, 05 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/169923.php http://www.medicalnewstoday.com/articles/169923.php A WHO official on Tuesday backed the Afghan government's decision to declare H1N1 (swine flu) a health emergency, forcing the closure of all schools in the country for three weeks in an effort to contain the virus, IRIN reports. Swine Flu Thu, 05 Nov 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/169879.php http://www.medicalnewstoday.com/articles/169879.php The World Health Organization recently declared H1N1 swine flu a global pandemic, resulting in the creation of rigorous vaccination programs worldwide. Children are among those considered particularly susceptible to contracting swine flu and are viewed as a top priority in receiving this vaccine. Most H1N1 swine flu vaccines are prepared from virus grown in chicken's eggs, resulting in a vaccine that contains remnants of egg proteins. Swine Flu Thu, 05 Nov 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/169883.php http://www.medicalnewstoday.com/articles/169883.php Immunity to whooping cough lasts at least 30 years on average, much longer than previously thought, according to a new study by researchers based at the University of Michigan and the University of New Mexico. Details are published October 30 in the open-access journal PLoS Pathogens. Immune System / Vaccines Thu, 05 Nov 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/169845.php http://www.medicalnewstoday.com/articles/169845.php Hoping to keep the flu at bay? A strong immune system helps. Enjoying the bounty of colorful fruits and vegetables available right now can be an important step toward supporting your family's immune system this cold/flu season. In addition to vitamins, minerals and fiber, fruits and vegetables contain phytonutrients, believed to come from the com-pounds that give these foods their vibrant colors. Flu / Cold / SARS